Rhea N. Coler - Concepedia

Author

Rhea N. Coler

Infectious Disease Research Institute ORCID

Also Known As

Abdelaal, Hazem F. M., Brett Leav, Coler, Rhea N, R. N. COLER, R. N. Coler, R.N. Coler, Rhea Coler, Rhea N Coler, Rhea N. Coler, Rhea N. Coler

188

Publications

13.8K

Citations

H-Index

Concepts

All Affiliations

Infectious Disease Research Institute University of Washington PAI Life Sciences (United States)Corixa Corporation Colorado State University

About

Rhea N. Coler is an author at Infectious Disease Research Institute specializing in immunology, medicine, and vaccination.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	33	51	3.6K
2	Allergy	6	6	236
3	Natural Sciences	2	2	139
4	Biochemistry	1	1	103
5	Biomedical Engineering	1	1	34

Rhea N. Coler

115

Publications

12.4K

Citations

H-Index

Page 1

	Year	Citations
An mRNA Vaccine against SARS-CoV-2 — Preliminary Report Lisa A. Jackson, Evan J. Anderson, Nadine Rouphael, New England Journal of Medicine	2020	3.4K
New horizons in adjuvants for vaccine development Steven G. Reed, Sylvie Bertholet, Rhea N. Coler, Trends in Immunology VaccinologyVaccinationVaccine DevelopmentImmunologyVaccine Design	2008	611
Homologous and Heterologous Covid-19 Booster Vaccinations Robert L. Atmar, Kirsten E. Lyke, Meagan E. Deming, New England Journal of Medicine	2022	603
Development and Characterization of Synthetic Glucopyranosyl Lipid Adjuvant System as a Vaccine Adjuvant Rhea N. Coler, Sylvie Bertholet, Magdalini Moutaftsi, PLoS ONE	2011	310
A Defined Tuberculosis Vaccine Candidate Boosts BCG and Protects Against Multidrug-Resistant <i>Mycobacterium tuberculosis</i> Sylvie Bertholet, Gregory C. Ireton, Diane Ordway, Science Translational Medicine	2010	301
Different human vaccine adjuvants promote distinct antigen-independent immunological signatures tailored to different pathogens Niels Peter Hell Knudsen, Anja Weinreich Olsen, Cecilia Buonsanti, Scientific Reports	2016	229
Leish-111f, a Recombinant Polyprotein Vaccine That Protects against Visceral Leishmaniasis by Elicitation of CD4<sup>+</sup>T Cells Rhea N. Coler, Yasuyuki Goto, Lisa Bogatzki, Infection and Immunity	2007	198
Vaccination with Heat-killed Leishmania Antigen or Recombinant Leishmanial Protein and CpG Oligodeoxynucleotides Induces Long-Term Memory CD4<b>+</b>and CD8<b>+</b>T Cell Responses and Protection Against <i>Leishmania major</i> Infection Elizabeth G. Rhee, Susana Méndez, Javeed A. Shah, The Journal of Experimental Medicine	2002	170
Identification of Human T Cell Antigens for the Development of Vaccines against <i>Mycobacterium tuberculosis</i> Sylvie Bertholet, Gregory C. Ireton, Maria Kahn, The Journal of Immunology	2008	169
A Nanostructured Lipid Carrier for Delivery of a Replicating Viral RNA Provides Single, Low-Dose Protection against Zika Jesse H. Erasmus, Amit P. Khandhar, Jeff Guderian, Molecular Therapy	2018	166

Page 1